Chiara F. Sugrue, MBA, MS, SCT(ASCP)

References
• Burlingame OO, Kesse’ KO, Silverman SG, Cibas ES. On‐Site Adequacy Evaluation performed by Cytotechnologists: Correlation with final
Interpretation of 5241 image‐guided Fine Needle Aspiration Biopsies. Cancer Cytopathol. 2011.
• Eedes CR, Wang HH. Cost‐effectiveness of immediate specimen adequacy assessment of thyroid fine‐needle aspirations. Am J Clin Pathol. 2004;
121: 64‐69
• Nasuti JF, Gupta PK, Baloch ZW. Diagnostic value and cost‐effectiveness of fine‐needle aspirations specimens: review of 5,688 cases. Diagn
Cytopathol. 2002; 27: 1‐4
• Andonian S. Okeke Z. Okeke DA, Sugrue C, Wasserman PG, Lee BR. Number of needle passes does not correlate with the diagnostic yield of
renal fine needle aspiration cytology. J Endourol. 2008; 22: 2377‐2380.
• Alsohaibani F, Girgis S, Sandha GS. Does onsite Cytotechnology evaluation improve the accuracy of endoscopic ultrasound‐guided fine‐needle
aspiration biopsy Can J Gastroenterol. 2009;23: 26‐30
• Layfield LJ, Bentz JS, Gopez EV. Immediate on‐site interpretation of fine‐needle aspiration smears: a cost and compensation analysis. Cancer.
2001; 93: 319‐322.
• Gupta PK. Progression from on‐site to point‐of‐care fine needle aspiration service: Opportunities and challenges. CytoJournal. 2010; 7:6
• Dhillon I, Pitman MB, DeMay RM, Archuletta P, Shidham V. Compensation crisis related to the onsite adequacy evaluation during FNA
procedure. Urgent proactive input from Cytopathology community is crucial to establish appropriate reimbursement for CPT code 88172 (or
its new counterpart if introduced in the future). CytoJournal 2010; 7:23
• Al‐Abbadi MA, Bloom LI, Fatheree LA, Haack LA, Minokowitz G, Wilbur DC, Austin MR. Adequate reimbursement is crucial to support costeffective
rapid on –site Cytopathology evaluations. CytoJournal 2010; 7:22
• Davey DD, Neal MH. Coding charges in the United States front and center: Implications for Cytopathology. Cancer Cytopathol. 2011.
• Ghofrani M, Beckman D, Rimm DL. The value of onsite adequacy assessment of thyroid fine‐needle aspirations is a function of operator
experience. Cancer Cytopathol. 2006; 108: 110‐113.
• American Medical Association. Pathology and Laboratory. In CPT ® (Current Procedural Terminology) 2011 Professional Edition. Chicago:
American Medical Association; 2010: 433‐435.
• US Department of Health and Human Services, Center for Medicare and Medicaid Services. 2011 MLN Matters Articles, MM7727.
http://www.cms.gov/MLN‐MattersArticles/2011Mman.
• Zhu W, Michael CW. How important is onsite adequacy assessment for Thyroid FNA: An evaluation of 883 cases. Diagn Cytopathol. 2007;35:
183‐186.
• Woon C, Bardales RH, Stanley MW, Stelow EB. Rapid Assessment of fine needle aspiration and final diagnosis: How often and why the
diagnoses are changed CytoJournal 2016; 6:25.
24